Search research articles
Contact Us
Filters
Showing results (51-60 of 112) with videos related to
Page
of 12
Sort By:
Leukemia & Lymphoma
|
July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea
Genevieve Douglas, Claire Harrison, Cecily Forsyth, et al.
Leukemia & Lymphoma
|
June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
Jane A Freeman, Kyle R Crassini, O Giles Best, et al.
Circulation
|
December 21, 2006
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)
Victor J Dzau, Elliott M Antman, Henry R Black, et al.
Investigative Ophthalmology & Visual Science
|
April 1, 2016
Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis
Jing Hua, William Stevenson, Thomas H Dohlman, et al.
Pathology
|
April 27, 2016
Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms
Juliana Andrici, Mahtab Farzin, Adele Clarkson, et al.
Circulation. Arrhythmia and Electrophysiology
|
June 16, 2021
Irrigated Needle Ablation Compared With Other Advanced Ablation Techniques for Failed Endocardial Ventricular Arrhythmia Ablation
Ryohsuke Narui, Shinichi Tanigawa, Ikutaro Nakajima, et al.
British Journal of Haematology
|
February 4, 2015
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia
Andrew Wei, Peter Tan, Sarah Perruzza, et al.
Circulation
|
December 21, 2006
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions
Victor J Dzau, Elliott M Antman, Henry R Black, et al.
Acta Neuropathologica Communications
|
February 9, 2019
White matter capillaries in vascular and neurodegenerative dementias
Yoshiki Hase, Ren Ding, Gina Harrison, et al.
Blood Advances
|
June 30, 2018
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
Anthony S Stein, Richard A Larson, Andre C Schuh, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 112) with videos related to
Sort By:
Page
of 12
Leukemia & Lymphoma
|
July 26, 2016
Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea
Genevieve Douglas, Claire Harrison, Cecily Forsyth, et al.
Leukemia & Lymphoma
|
June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia
Jane A Freeman, Kyle R Crassini, O Giles Best, et al.
Circulation
|
December 21, 2006
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease)
Victor J Dzau, Elliott M Antman, Henry R Black, et al.
Investigative Ophthalmology & Visual Science
|
April 1, 2016
Graft Site Microenvironment Determines Dendritic Cell Trafficking Through the CCR7-CCL19/21 Axis
Jing Hua, William Stevenson, Thomas H Dohlman, et al.
Pathology
|
April 27, 2016
Mutation specific immunohistochemistry is highly specific for the presence of calreticulin mutations in myeloproliferative neoplasms
Juliana Andrici, Mahtab Farzin, Adele Clarkson, et al.
Circulation. Arrhythmia and Electrophysiology
|
June 16, 2021
Irrigated Needle Ablation Compared With Other Advanced Ablation Techniques for Failed Endocardial Ventricular Arrhythmia Ablation
Ryohsuke Narui, Shinichi Tanigawa, Ikutaro Nakajima, et al.
British Journal of Haematology
|
February 4, 2015
Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia
Andrew Wei, Peter Tan, Sarah Perruzza, et al.
Circulation
|
December 21, 2006
The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions
Victor J Dzau, Elliott M Antman, Henry R Black, et al.
Acta Neuropathologica Communications
|
February 9, 2019
White matter capillaries in vascular and neurodegenerative dementias
Yoshiki Hase, Ren Ding, Gina Harrison, et al.
Blood Advances
|
June 30, 2018
Exposure-adjusted adverse events comparing blinatumomab with chemotherapy in advanced acute lymphoblastic leukemia
Anthony S Stein, Richard A Larson, Andre C Schuh, et al.
Page
of 12